Following numerous company acquisitions, one of the world’s largest pharmaceutical companies faced the challenge of
consolidating thousands of servers and applications across their global data centers.
Partnering with EMC, VCE, VMware and the company’s vendor network, Align led the planning and transition of
the client’s infrastructure from their legacy environment to a virtual platform, using Vblock technology in their four
core global data centers—all while minimizing risk for every affected business unit.
Align managed the application tabletops and infrastructure checkpoints and developed a communication
strategy for senior-level program meetings that kept the transformation plan, detail migration schedules and
implementation procedures visible to key stakeholders.
The Align migration methodology and experience provided the ability to:
Align engaged with key stakeholders within every business unit to validate legacy applications and infrastructure
and to ensure a seamless transition into the new virtual platform. As the Vblock systems were brought online,
Align led the implementation and testing of each service environment across the four data centers, ensuring the
environments at each site were available to those business units.
The virtualization transformation initiative was the largest virtualization project ever completed by this client. Their
business units have reported feedback of immediate application performance improvements from the dynamic
resource monitoring and on-the-fly scalability that the Vblock platform provides.
As business units expand or contract, so will the computing, storage and network capacity, allowing for scalable
performance and cost savings. Because the Vblock virtual platform empowers the pharmaceutical company’s
business units to pay for only the technology resources that are needed, they are projecting savings of over $50
million in business technology costs.